arXiv:2603. 19186v3 Announce Type: replace Abstract: Randomized controlled trials (RCTs) are the gold standard for estimating treatment effects, yet they are often underpowered for detecting effect heterogeneity.
arXiv:2608. 08288v1 Announce Type: new Abstract: Estimating counterfactual outcomes over time from longitudinal observational data is central to clinical decision support.
arXiv:2604. 23904v3 Announce Type: replace-cross Abstract: Synthetic tabular data are often evaluated by distributional similarity, privacy distance, or train-on-synthetic-test-on-real predictive performance, but these criteria do not ensure validity for causal inference.
arXiv:2606. 05797v1 Announce Type: new Abstract: Longitudinal treatment decisions require predicting potential outcomes under future treatment sequences in the presence of time-varying confounding, heterogeneous patient dynamics, and limited domain-specific data.
arXiv:2607. 26599v1 Announce Type: new Abstract: Estimating heterogeneous treatment effects is central to targeted interventions, such as personalized promotions and precision medicine.
Estimating heterogeneous treatment effects is central to targeted interventions, such as personalized promotions and precision medicine. We focus on the conditional average treatment effect (CATE), a standard estimand for characterizing such heterogeneity.
arXiv:2604. 16763v3 Announce Type: replace Abstract: Causal inference from electronic health records (EHR) is fundamentally limited by unmeasured confounding: critical clinical states such as frailty, goals of care, and mental status are documented in free-text notes but absent from structured data.
arXiv:2607. 21806v1 Announce Type: new Abstract: Predictive machine learning (ML) models are increasingly used to aid human decision-makers across various high-risk domains such as healthcare and criminal justice.
arXiv:2507. 14661v2 Announce Type: replace-cross Abstract: Semi-supervised domain adaptation (SSDA) seeks to achieve accurate predictions in a target domain with limited labeled target data by exploiting abundant source and unlabeled target data.
arXiv:2507. 20993v4 Announce Type: replace-cross Abstract: We study how to learn treatment policies from multimodal electronic health records (EHRs) that consist of tabular data and clinical text.
arXiv:2607. 27224v1 Announce Type: cross Abstract: External and synthetic control arms (ECAs) are entering psychiatric drug development, but the field lacks a benchmark that evaluates the properties regulators care about: not only how accurately a method reconstructs untreated trajectories, but whether its uncertainty is calibrated, whether it is robust to the informative observation times common in mental-health records (sicker patients are seen more often), and what false-positive rate it induces in go/no-go trial decisions.
arXiv:2606. 27114v1 Announce Type: new Abstract: Uplift modeling, crucial for estimating individual treatment effects (ITE), faces dual challenges: flexibly leveraging inter-group similarity to enhance discriminative power and debiasing under unobserved confounding scenarios.
arXiv:2606. 03332v1 Announce Type: new Abstract: Probabilistic models are typically trained using task-agnostic objectives like log-loss, which can lead to significant errors in downstream estimation.